Mutant Alpha-1-Antitrypsin Compositions and Use Thereof

Eli Chaim Lewis; LIOR Yotam

Mutant Alpha-1-Antitrypsin Compositions and Use Thereof

Eli Chaim Lewis (Inventor)
, LIOR Yotam (Inventor)

Department of Clinical Biochemistry and Pharmacology

Research output: Patent

Abstract

The present invention provides mutant alpha 1-antitrypsin proteins, pharmaceutical compositions comprising the same, and methods of use thereof in treatment of subjects with an inflammatory disease or disorder.

Original language	English
Patent number	US20200140524A1
State	Published - 7 May 2020

Cite this

@misc{cea1c05b1aa04c3aa8d5880784669ed5,

title = "Mutant Alpha-1-Antitrypsin Compositions and Use Thereof",

abstract = "The present invention provides mutant alpha 1-antitrypsin proteins, pharmaceutical compositions comprising the same, and methods of use thereof in treatment of subjects with an inflammatory disease or disorder. ",

author = "Lewis, \{Eli Chaim\} and LIOR Yotam",

note = "US Patent App. 16/499,534; US20200140524A1",

year = "2020",

month = may,

day = "7",

language = "English",

publisher = "Google Patents",

type = "Patent",

}

TY - PAT

T1 - Mutant Alpha-1-Antitrypsin Compositions and Use Thereof

AU - Lewis, Eli Chaim

AU - Yotam, LIOR

N1 - US Patent App. 16/499,534

PY - 2020/5/7

Y1 - 2020/5/7

N2 - The present invention provides mutant alpha 1-antitrypsin proteins, pharmaceutical compositions comprising the same, and methods of use thereof in treatment of subjects with an inflammatory disease or disorder.

AB - The present invention provides mutant alpha 1-antitrypsin proteins, pharmaceutical compositions comprising the same, and methods of use thereof in treatment of subjects with an inflammatory disease or disorder.

M3 - Patent

M1 - US20200140524A1

PB - Google Patents

ER -

Mutant Alpha-1-Antitrypsin Compositions and Use Thereof

Abstract

Fingerprint

Cite this